Download full report with analyst certification and important disclosures
Nov 5 2019, 10:10 GMT
DSM-Firmenich
Solid Q3 update despite muted revenue out-turn
- Sectors : Foods
- Companies : DSM-Firmenich
DAVY VIEW
Q3 trends across the group were consistent with Q2, although headwinds relating to African Swine Fever (ASF) intensified and are now impacting sales performance in the Animal Nutrition segment. We believe the effects of ASF will be long-dated and pervasive. The argument for an equity re-rating is limited until evidence of a more sustained recovery in Nutrition organic growth materialises. Innovation platforms continue to make incremental progress. We envisage no material change to our FY19 EBITDA forecast.
